#45: Clopidogrel pharmacogenomics: Challenges, controversies, and clinical implications with Dr Jessica Mega
Clopidogrel pharmacogenomics: Challenges, controversies, and clinical implications with Dr Jessica Mega (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - February 10, 2012 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#127: Wine and chocolate: Flavonoid and polyphenol research; clopidogrel plus aspirin: No benefit for stroke prevention; wireless power delivery for LVADs; TRA 2°P: Vorapaxar meets end point but ups bleeding
Wine and chocolate: Flavonoid and polyphenol research; clopidogrel plus aspirin: No benefit for stroke prevention; wireless power delivery for LVADs; TRA 2°P: Vorapaxar meets end point but ups bleeding (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - February 10, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#126: Patient care concerns ignored, careers destroyed, claim docs; heart attack deaths plummet in three EU nations; "valve-on-a-stick" transaortic TAVI alternative to transfemoral; Vytorin US label updated; risk begins with middle-age risk factors
Patient care concerns ignored, careers destroyed, claim docs; heart attack deaths plummet in three EU nations; "valve-on-a-stick" transaortic TAVI alternative to transfemoral; Vytorin US label updated; risk begins with middle-age risk factors (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - February 3, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#125: Cardiologists accused of defrauding Medicare; treat risk and not LDL-cholesterol targets; PLATO: PPI analysis "raises flag"; "recalled" Riata ICD leads: summit aims for guidance; statins: to prescribe or not to prescribe?
Cardiologists accused of defrauding Medicare; treat risk and not LDL-cholesterol targets; PLATO: PPI analysis "raises flag"; "recalled" Riata ICD leads: summit aims for guidance; statins: to prescribe or not to prescribe? (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - January 27, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#124: Resveratrol researchers on Das fraud scandal; BRIDGE study published; US bleeding ADRs: dabigatran vs warfarin; statins: four times more costly in US than UK; dronedarone gets another chance in combo trial
Resveratrol researchers on Das fraud scandal; BRIDGE study published; US bleeding ADRs: dabigatran vs warfarin; statins: four times more costly in US than UK; dronedarone gets another chance in combo trial (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - January 20, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#123: Obesity: Focus on excess calories; Informed consent in patient's death after stem-cell treatment; Dabigatran: New data on MI and ischemic events; Serum potassium targets in acute MI; RESPECT PFO/stroke trial completes enrollment
Obesity: Focus on excess calories; Informed consent in patient's death after stem-cell treatment; Dabigatran: New data on MI and ischemic events; Serum potassium targets in acute MI; RESPECT PFO/stroke trial completes enrollment (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - January 13, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#44: Improving patient adherence to medication with Dr Eric Peterson
Patient adherence to medication has long defied quantification, with many physicians assuming that the cost of medications is the primary factor explaining poor rates of compliance. How do we explain abysmal rates of patient adherence to medication? (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - January 9, 2012 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#122: Top news in 2011--Apixaban win in ARISTOTLE; the heart can repair itself; dalcetrapib passes test in dal-VESSEL; FDA restricts simvastatin 80 mg; NIH stops AIM-HIGH; poor long-term outcomes post ablation of AF; caution with dabigatran in elderly; FD
Top news in 2011--Apixaban win in ARISTOTLE; the heart can repair itself; dalcetrapib passes test in dal-VESSEL; FDA restricts simvastatin 80 mg; NIH stops AIM-HIGH; poor long-term outcomes post ablation of AF; caution with dabigatran in elderly; FDA (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - December 29, 2011 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#121: Vitamin D fails again to affect CV mortality; more overstenting charges in Maryland; data show antihypertensive therapy prolongs life; ALTITUDE halted; RECOVER II on benefit of dabigatran in treatment of VTE
Vitamin D fails again to affect CV mortality; more overstenting charges in Maryland; data show antihypertensive therapy prolongs life; ALTITUDE halted; RECOVER II on benefit of dabigatran in treatment of VTE (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - December 23, 2011 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#120: CardioMEMS implantable PA-pressure monitor rejected by FDA; iPad app streams real-time data; bleeding in AF: European consensus; concern over Pfizer's Lipitor deals; cardiologists support elective PCI without on-site CABG: Survey
CardioMEMS implantable PA-pressure monitor rejected by FDA; iPad app streams real-time data; bleeding in AF: European consensus; concern over Pfizer's Lipitor deals; cardiologists support elective PCI without on-site CABG: Survey (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - December 16, 2011 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#119: Stents, ICDs, inappropriate? Then CMS won't pay; FDA investigating serious bleeding events with dabigatran; Generic atorvastatin now in US; CV risk negligible with COX-2 inhibitors but AF a possible concern; noncardiac chest pain
Stents, ICDs, inappropriate? Then CMS won't pay; FDA investigating serious bleeding events with dabigatran; Generic atorvastatin now in US; CV risk negligible with COX-2 inhibitors but AF a possible concern; noncardiac chest pain (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - December 9, 2011 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#43: Same-day discharge from the hospital after elective PCI with Dr Sunil Rao
What is the best way to care for patients following PCI? Is same-day discharge a viable—or even desirable—option? Dr Sunil Rao joins the show to discuss his recent paper in JAMA, including the background for the study, source of data, and methodology. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - December 7, 2011 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#118: CONFIRM CT registry raises more questions; CHADS2 predicts AF problems; Batting Big Tobacco; 30-day readmissions following PCI
Published each Friday, this podcast delivers the week's five most popular articles in audio format. Stay on top of the latest cardiology news, wherever your week takes you. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - December 2, 2011 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#117: Dabigatran fatal bleeds; Vitamin D; Sodium J-curve; Erasmus MC fires Poldermans; postshock driving restrictions
Dabigatran fatal bleeds; Vitamin D; Sodium J-curve; Erasmus MC fires Poldermans; postshock driving restrictions (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - November 25, 2011 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
